The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


ALDACTONE

25 Milligram Film Coated Tablet

Primecrown 2010 LtdPPA1633/030/001

Main Information

Trade NameALDACTONE
Active SubstancesSPIRONOLACTONE
Strength25 Milligram
Dosage FormFilm Coated Tablet
Licence HolderPrimecrown 2010 Ltd
Licence NumberPPA1633/030/001

Group Information

ATC CodeC03DA01 spironolactone

Status

Authorised/WithdrawnAuthorised
Licence Issued13/09/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back